| Authors: |
El Garch F; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Vétoquinol S.A., Lure, France., de Jong A; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Bayer Animal Health GmbH, Leverkusen, Germany., Simjee S; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Elanco Animal Health, Basingstoke, UK., Moyaert H; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Zoetis, Zaventem, Belgium., Klein U; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Elanco Animal Health, Basingstoke, UK., Ludwig C; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Bayer Animal Health GmbH, Leverkusen, Germany., Marion H; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; European Animal Health Study Centre (CEESA), Brussels, Belgium., Haag-Diergarten S; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany., Richard-Mazet A; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; Merial, Lyon, France., Thomas V; VetPath Study Group, c/o CEESA, 168 Ave de Tervueren, 1150 Brussels, Belgium; MSD Animal Health, Schwabenheim, Germany., Siegwart E; LGC, Fordham, UK,. Electronic address: anno.jong@bayer.com. |